FDA calls for Hatch-Waxman tweak, accelerated approval reforms in President Biden's 2023 budget proposal
As the FDA has received its fair share of vilification and staffers working exceedingly long hours since the pandemic began, President Biden’s 2023 budget request is looking to provide the agency with a major infusion of new funds — $2.1 billion, or 34% above FDA’s budget this year.
That vast majority of those new funds will be directed at prepping for the next pandemic, or the next iteration of the current one. Within an HHS-wide total of $81.7 billion in 2023 pandemic funds, $1.6 billion is included for FDA to expand and modernize pandemic-related regulatory capacity, IT and lab infrastructure.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
